Pharmaceutical Commerce - September/October 2016

Largest industry gathering for temperature-controlled logistics and distribution

The growing market for self-administered injectables calls for better patient-training resources

A host of evaluation methodologies are defining ‘value’ in drug prices

Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs

Vendors and service providers scramble to serve a growing market

Morris & Dickson publishes a family and company history

Ten payer pressures to act on now

Sponsored by TGaS Advisors

Substantial investments have been made, but beneficial results hard to identify, says ZS Associates

Applying specialty-pharma techniques to a potentially mass-market drug

Company pairs up with Clemson University professor for online and in-person training

Vendors and users come together to standardize communication protocols

Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs

‘Operation Black Market Meds’ involved New York State, Florida and federal investigators

Deal deepens Teva’s business in generics

Consumer Products Safety Commission steps into distribution of a generic form of Ambien

Emphasis is on cold chain capabilities, dedicated global network

AAPA is positioning itself to provide alternative certification